Scott Galasinski, Ph.D., brings over two decades of diverse healthcare experience to his role as Head of External Innovation at Elanco. His background spans early discovery research, translational and clinical research, and strategy and business development within leading pharmaceutical and biotech companies, including Abbott Laboratories, AbbVie, Ultragenyx, Novartis Gene Therapies, and AstraZeneca. Dr. Galasinski earned his Ph.D. from the University of Colorado, Boulder and completed an HHMI postdoctoral fellowship at Pennsylvania State University.